Soleno Therapeutics (SLNO) Accounts Payables (2013 - 2026)
Soleno Therapeutics (SLNO) posted quarterly Accounts Payables of $12.4 million for Q1 2026, up 125.9% year-over-year from $5.5 million in Q1 2025, and little changed quarter-over-quarter from $12.4 million in Q4 2025.
Soleno Therapeutics (SLNO) Accounts Payables (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has reported Accounts Payables for 14 consecutive years, with $12.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 125.9% year-over-year to $12.4 million; the TTM figure through Mar 2026 stood at $12.4 million (up 125.9% YoY), while the FY2025 annual figure was $12.4 million, up 40.0% from the prior year.
- Accounts Payables held at $12.4 million in Q1 2026 per SLNO's latest filing, from $12.4 million in the prior quarter.
- Across five years, Accounts Payables topped out at $12.4 million in Q4 2025 and bottomed at $1.8 million in Q4 2022.
- Historically, Accounts Payables has averaged $5.5 million across 5 years, with a median of $3.7 million in 2024.
- Annual changes were most pronounced in 2022 — Accounts Payables plunged 48.36% — and 2024, when it soared 188.77%.
- Soleno Therapeutics' Accounts Payables stood at $1.8 million in 2022, then jumped by 77.21% to $3.1 million in 2023, then surged by 182.06% to $8.9 million in 2024, then jumped by 40.0% to $12.4 million in 2025, then dropped by 0.39% to $12.4 million in 2026.
- Business Quant data shows SLNO's Accounts Payables at $12.4 million in Q1 2026, $12.4 million in Q4 2025, and $8.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn | 12.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.39 Mn |
| Dec 31, 2025 | 12.44 Mn |
| Sep 30, 2025 | 8.15 Mn |
| Jun 30, 2025 | 6.22 Mn |
| Mar 31, 2025 | 5.48 Mn |
| Dec 31, 2024 | 8.88 Mn |
| Sep 30, 2024 | 6.24 Mn |
| Jun 30, 2024 | 3.72 Mn |
| Mar 31, 2024 | 8.02 Mn |
| Dec 31, 2023 | 3.15 Mn |
| Sep 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 3.44 Mn |
| Mar 31, 2023 | 2.78 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2022 | 2.32 Mn |
| Jun 30, 2022 | 2.41 Mn |
| Mar 31, 2022 | 2.41 Mn |
| Dec 31, 2021 | 3.25 Mn |
| Sep 30, 2021 | 3.86 Mn |
| Jun 30, 2021 | 3.35 Mn |